Interestingly, FBXO28 is found to exert either oncogenic or tumor suppressing functions by targeting MYC, SMARCC2 or HIF-1α, under different cellular contexts, complicating its role in tumorigenesis and metastasis [12, 13, 32]. The gene discussed is SMARCC2; the disease is neoplasm.